osimertinib in advanced egfr t790m-mutant nsclc
Published 5 years ago • 958 plays • Length 3:02Download video MP4
Download video MP3
Similar videos
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
3:59
osimertinib for egfr t790m resistance mutations in nsclc
-
1:40
dr. ramalingam on the role of osimertinib in egfr t790m-positive advanced nsclc
-
5:45
osimertinib in t790m-mutant lung cancer
-
4:04
treating with osimertinib in egfr-mutated nsclc
-
1:57
dr. wakelee on benefits of osimertinib in egfr-mutant nsclc treatment
-
0:42
dr. fidler discusses osimertinib in egfr-mutated lung cancer
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
2:50
sequencing with osimertinib in egfr-mutated nsclc
-
6:50
osimertinib: a potential new standard of care for advanced egfr-mutated nsclc | suresh ramalingam
-
2:03
dr. wakelee on rationale to explore osimertinib with concurrent chemotherapy in egfr-mutant nsclc
-
3:47
afatinib therapy for uncommon egfr alterations in nsclc
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
5:29
osimertinib for the t790m resistance mutation
-
1:35
dr. herbst on the benefit of adjuvant osimertinib in egfr-mutant nsclc
-
2:11
dr. low on osimertinib versus dacomitinib in egfr-mutant nsclc
-
1:44
dr. oxnard on delaying second-line treatment in egfr-mutant lung cancer
-
3:34
repeat biopsy in lung cancer patients with egfr mutation